MetaCap

Haemonetics (HAE) vs Teleflex (TFX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Haemonetics (HAE) has outperformed Teleflex (TFX) over the past year, gaining 52.5% versus a gain of 46.6%. Over five years, HAE leads with a +131.4% price change compared with -47.0% for TFX. Teleflex is the larger company by market cap ($6.41 billion vs $5.47 billion), about 1.2 times the size.

On valuation, Teleflex trades at a lower forward P/E (14.8x vs 19.2x for Haemonetics). Teleflex pays a dividend yielding 0.84%, while Haemonetics does not currently pay one. Haemonetics converts more of its revenue into profit, with a net margin of 7.3% versus -45.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HAE+52.51%TFX+46.58%
+66%+14%-38%
Nov 21, 20251 yearNov 20, 2026
HAE+113.92%TFX-49.32%
+128%+26%-77%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HAE versus TFX key metrics
MetricHAETFX
Share price$120.16$161.58
Market cap$5.47B$6.41B
1-day change-0.17%-1.11%
YTD return+49.92%+32.40%
1-year return+52.51%+46.58%
5-year return+131.43%-47.05%
P/E ratio (TTM)53.1779.60
Forward P/E19.1714.77
EPS (TTM)$2.26$2.03
Dividend yield0.00%0.84%
Annual dividend$0.00$1.36
Revenue (latest FY)$1.33B$1.99B
Revenue growth (YoY)-1.97%+17.25%
Net income (latest FY)$97.31M$-905.64M
Gross margin59.04%56.24%
Operating margin11.75%5.94%
Net margin7.29%-45.45%
52-week high$132.00$166.75
52-week low$51.00$100.18
Distance from 52-week high-8.97%-3.10%
Analyst consensusbuybuy
Avg. price target upside+22.49%+4.03%
Average volume659.70K790.19K
Shares outstanding45.54M39.66M
Employees3,00915,500
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Teleflex trades at a higher earnings multiple (79.6x vs 53.2x trailing P/E).
  • Haemonetics is more profitable, keeping 7.3 cents of every revenue dollar as net income versus -45.4 cents for Teleflex.
  • Teleflex grew revenue faster in its latest fiscal year (+17.25% vs -1.97%).

About Haemonetics

HAE stock →

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.

Health Care · Medical/Dental Instruments · 3,009 employees

About Teleflex

TFX stock →

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.

Health Care · Medical/Dental Instruments · 15,500 employees

HAE vs TFX FAQ

Which is bigger, Haemonetics or Teleflex?

Teleflex (TFX) is larger, with a market capitalization of $6.41B compared with $5.47B for Haemonetics (HAE).

Which stock has performed better over the past year, HAE or TFX?

HAE returned +52.51% over the past 12 months, compared with +46.58% for TFX (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, HAE or TFX?

HAE has the lower trailing P/E at 53.2, versus 79.6 for TFX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Haemonetics or Teleflex?

Teleflex pays a dividend yielding 0.84%, while Haemonetics does not currently pay a regular dividend.

Are Haemonetics and Teleflex in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons